Join to View Full Profile
500 S Henderson St Ste 300Fort Worth, TX 76104
Phone+1 817-413-1500
Fax+1 817-413-1499
Dr. LaFargue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2017
University of California (Irvine)Residency, Obstetrics and Gynecology, 2013 - 2017
New York Medical CollegeClass of 2013
Certifications & Licensure
CA State Medical License 2015 - 2026
TX State Medical License 2019 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen
Nature Communications. 2023-04-26 - 3 citationsClinical analysis of pathologic complete responders in advanced-stage ovarian cancer.Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, Alpa M Nick, Anca Chelariu-Raicu
Gynecologic Oncology. 2022-04-01 - 27 citationsCD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.Shaolin Ma, Lingegowda S. Mangala, W. Hu, Emine Bayaktar, Akira Yokoi
Cell Reports. 2021-08-17
Press Mentions
Meet Our Newest Gynecologic Oncologist, Dr. Christopher LaFargueSeptember 17th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
